ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

Roswell Park Prepares for Sequestration

February 22, 2013

In Brief: Sandor Eckhardt Is New UICC President; New Delhi Is Site Of 1994 UICC Meeting

August 31, 1990

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.

November 29, 1996